| P2093 | author name string | Mauro Di Ianni | |
| | Paolo Di Bartolomeo | |
| | Patrizia Accorsi | |
| | Stella Santarone | |
| | Paolo Sportoletti | |
| | Paola Olioso | |
| | Raffaella Giancola | |
| | Beatrice Del Papa | |
| | Franca Falzetti | |
| | Annalisa Natale | |
| | Ambra Di Tommaso | |
| | Bianca Fabi | |
| | Emanuela Rosati | |
| | Stefano Baldoni | |
| | Gabriele Papalinetti | |
| P2860 | cites work | Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 |
| | Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 | Q28591451 |
| | Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses | Q29619908 |
| | Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia | Q30415126 |
| | Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. | Q33624804 |
| | CD39/adenosine pathway is involved in AIDS progression | Q33959186 |
| | Advances in graft-versus-host disease biology and therapy | Q34031916 |
| | CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice | Q34091467 |
| | Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation | Q34162461 |
| | A central role for Notch in effector CD8(+) T cell differentiation | Q34517022 |
| | Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease. | Q34568892 |
| | Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis | Q34620456 |
| | Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new. | Q34754302 |
| | Long-term survival and late deaths after allogeneic hematopoietic cell transplantation | Q35023409 |
| | Profound depletion of host conventional dendritic cells, plasmacytoid dendritic cells, and B cells does not prevent graft-versus-host disease induction | Q35884088 |
| | Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells | Q35909695 |
| | Control of peripheral tolerance by regulatory T cell-intrinsic Notch signaling. | Q36199919 |
| | Notch signalling during peripheral T-cell activation and differentiation | Q36684906 |
| | Delta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in mice | Q36717891 |
| | Blockade of individual Notch ligands and receptors controls graft-versus-host disease | Q36733439 |
| | Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells | Q36843721 |
| | T cell-specific notch inhibition blocks graft-versus-host disease by inducing a hyporesponsive program in alloreactive CD4+ and CD8+ T cells | Q36863927 |
| | Notch signaling at a glance | Q36903753 |
| | Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention | Q36925951 |
| | Therapeutic targeting of NOTCH signaling ameliorates immune-mediated bone marrow failure of aplastic anemia | Q36973664 |
| | Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation | Q37132892 |
| | Mechanisms Underlying CD4+ Treg Immune Regulation in the Adult: From Experiments to Models | Q37317297 |
| | gamma-Secretase in biology and medicine | Q37375252 |
| | The different faces of Notch in T-helper-cell differentiation | Q37376021 |
| | Glucocorticoid-refractory acute graft-versus-host disease | Q37680126 |
| | Pathophysiology of GvHD and Other HSCT-Related Major Complications | Q37710572 |
| | Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands | Q37730667 |
| | T regulatory cell separation for clinical application. | Q38026324 |
| | Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models. | Q38696697 |
| | Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation? | Q38742863 |
| | The mazy case of Notch and immunoregulatory cells. | Q39178393 |
| | Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts | Q39244446 |
| | "Designed" grafts for HLA-haploidentical stem cell transplantation | Q39289225 |
| | Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity | Q41110821 |
| | Graft-versus-leukemia reactions after bone marrow transplantation | Q41198977 |
| | Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets | Q42066000 |
| | CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation | Q44408941 |
| | HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse. | Q44458617 |
| | Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. | Q45834735 |
| | A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood | Q46284741 |
| | An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD. | Q47709978 |
| | Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT. | Q48105490 |
| | Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets | Q49552733 |
| | Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy | Q49679320 |
| | New Insights into Graft-Versus-Host Disease and Graft Rejection. | Q50425146 |
| | Notch pathway plays a novel and critical role in regulating responses of T and antigen-presenting cells in aGVHD. | Q51369795 |
| | Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia. | Q51765546 |
| | The NOTCH1/CD39 axis: a Treg trip-switch for GvHD. | Q52872585 |
| | Peripheral tissues reprogram CD8+ T cells for pathogenicity during graft-versus-host disease. | Q55260254 |
| | Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling | Q61638150 |
| | Graft-versus-leukemia in rat MHC-mismatched bone marrow transplantation is merely an allogeneic effect | Q72010900 |
| | Mesenchymal cells recruit and regulate T regulatory cells | Q80717999 |
| | A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses | Q81357571 |
| | Inducing and expanding regulatory T cell populations by foreign antigen | Q81392563 |
| | Notch signaling in the immune system | Q82881379 |
| | Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction | Q85476385 |
| | Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies | Q85486402 |
| | T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantati | Q86169061 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell | Q7868 |
| | transcription factor | Q407384 |
| | membrane protein | Q423042 |
| | hematopoietic stem cell transplantation | Q1128050 |
| | graft-versus-host disease | Q1194520 |
| | hemic and immune systems | Q70202933 |
| P304 | page(s) | 1825 | |
| P577 | publication date | 2018-01-01 | |
| | 2018-08-10 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | NOTCH and Graft-Versus-Host Disease | |
| P478 | volume | 9 | |